Position in AGIO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,144,933
+$4,003,917 QoQ
Shares Held
165,587
+110.5% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 238 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. AGIO ranks #60 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in AGIO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,144,933 | 165,587 | Shares | Sole | 2026-08-11 | |
| 2025-12-31 | $2,141,016 | 78,656 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,987,580 | 74,429 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,211,562 | 36,427 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,093,769 | 37,330 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,195,930 | 97,259 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,928,308 | 110,923 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,623,322 | 130,411 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $40,501,179 | 1,818,643 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $43,935,383 | 1,775,167 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $61,187,512 | 2,160,576 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $42,210,062 | 1,837,617 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $45,793,594 | 1,630,826 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $56,168,746 | 1,986,165 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $38,346,429 | 1,729,654 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $46,966,918 | 1,613,429 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $41,694,608 | 1,268,470 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $50,801,135 | 1,100,783 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $82,449,850 | 1,496,096 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $80,532,631 | 1,559,501 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $78,963,768 | 1,822,381 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $63,193,970 | 1,805,542 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $85,054,110 | 1,590,391 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $44,456,227 | 1,252,994 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||